VeriMomVeriMom

cis-3-hexenyl cis-hexenoate hamilelikte güvenli mi?

No harmonised reproductive or teratogenic classification (no evidence of H360/H361) and no CIR or SCCS safety opinion flagging reproductive risk; the available RIFM fragrance safety assessment and flavoring specifications report no reproductive findings and support use as a fragrance/flavouring. Low but measurable systemic exposure is plausible from dermal use (lipophilic ester; logP ≈3.3), so exposure is scored as 1. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32028013/?utm_source=openai))

İçerikler
cis-3-hexenyl cis-hexenoate
BILINEN RISK YOK
93
/100
0

Related ingredients

Frequently asked questions

cis-3-hexenyl cis-hexenoate hamilelikte güvenli mi?
No harmonised reproductive or teratogenic classification (no evidence of H360/H361) and no CIR or SCCS safety opinion flagging reproductive risk; the available RIFM fragrance safety assessment and flavoring specifications report no reproductive findings and support use as a fragrance/flavouring. Low but measurable systemic exposure is plausible from dermal use (lipophilic ester; logP ≈3.3), so exposure is scored as 1. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32028013/?utm_source=openai))
cis-3-hexenyl cis-hexenoate emzirirken güvenli mi?
No data indicating reproductive or lactation-specific toxicity in available safety reviews (RIFM) or flavouring assessments (JECFA); no harmonised CLP reproductive classifications found. Systemic exposure potential from topical use is low but measurable, so exposure is scored 1 absent evidence of milk transfer. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32028013/?utm_source=openai))
cis-3-hexenyl cis-hexenoate bebek cildi için güvenli mi?
No infant-specific toxicity or developmental toxicity data were found and no harmonised reproductive classification; RIFM assessment and flavoring/usage listings do not flag developmental hazards. Because the substance is a moderately lipophilic ester with measurable dermal absorption in adults (low), infant skin exposure is expected to give higher per‑kg absorption (immature barrier, higher surface-area-to-weight), so exposure is increased by +1 for ages 0–3 (adult 1 → infant 2). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32028013/?utm_source=openai))
VeriMom cis-3-hexenyl cis-hexenoate nasıl puanlıyor?
VeriMom cis-3-hexenyl cis-hexenoate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
Hamilelikte cis-3-hexenyl cis-hexenoate yerine neler kullanılabilir?
Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.

Her etiketi 2 saniyede kontrol et

VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.

Tıbbi Sorumluluk Reddi

Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.

VeriMom uygulamasında tüm özellikleri keşfedin